However, when medulloblastoma patients were stratified according to mRNA levels at diagnosis, those with elevated MMP-2 expression displayed a better five- and ten-year overall survival than patients with low MMP-2 expression (Supplementary Figure S5A). This evidence concerns the gene MMP2 and medulloblastoma.